These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23778723)

  • 1. Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method.
    Quaglieri S; Gatti O; Rebecchi E; Manfrin M; Tinelli C; Mira E; Benazzo M
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1443-9. PubMed ID: 23778723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease.
    Harcourt JP; Lambert A; Wong PY; Patel M; Agarwal K; Golding JF; Bronstein AM
    Otol Neurotol; 2019 Apr; 40(4):491-496. PubMed ID: 30870364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results.
    Scarpa A; Ralli M; Cassandro C; Gioacchini FM; Alicandri-Ciufelli M; Viola P; Chiarella G; de Vincentiis M; Cassandro E
    Am J Otolaryngol; 2019; 40(6):102289. PubMed ID: 31537428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
    Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
    Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Vertigo Control and Vestibular Function After Low-dose On-demand Transtympanic Gentamicin for Refractory Menière's Disease.
    Nicolas S; Kmeid M; Mansour C; Fraysse B; Deguine O; Marx M; Fraysse ME
    Otol Neurotol; 2019 Feb; 40(2):218-225. PubMed ID: 30624404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin in monolateral Meniere's disease: our experience.
    Bertino G; Durso D; Manfrin M; Casati L; Mira E
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):271-5. PubMed ID: 16021460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of repeated intratympanic gentamicin for Ménière's disease.
    Nguyen KD; Minor LB; Della Santina CC; Carey JP
    Laryngoscope; 2009 Apr; 119(4):792-8. PubMed ID: 19213044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E; Pérez Fernández N
    Acta Otorrinolaringol Esp; 2004; 55(6):270-6. PubMed ID: 15491114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and preservation of hearing with low-dose gentamicin in unilateral meniere's disease: A clinical symptomatology-based study.
    Scarpa A; Avallone E; Carucci M; Salzano G; Chiarella G; Cassandro C; Viola P; Ricciardiello F; Ralli M; De Luca P; Salzano FA
    Am J Otolaryngol; 2024; 45(1):104116. PubMed ID: 37984050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS; Poe DS
    Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J
    Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease.
    Bodmer D; Morong S; Stewart C; Alexander A; Chen JM; Nedzelski JM
    Otol Neurotol; 2007 Dec; 28(8):1140-4. PubMed ID: 18084826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.